Inventurus Knowledge Solutions Limited — PPTs, 04-02-2026: Investor Presentation

IKS Health delivered a strong Q3 FY26, with revenue hitting **815 Cr**, a **24% YoY** jump. Adjusted profit (PAT) soared **48% YoY** to **215.4 Cr**, showcasing robust performance. EBITDA grew **40% YoY** to **281.6 Cr**, with margins at **34.6%**, supported by continuous cash generation.

The company's strategy focuses on AI-native platforms, including new agentic workflows for clinical documentation and autonomous coding. Key initiatives involve integrating the AQuity acquisition, establishing market leadership (ranked #1 in AI-driven RCM & medical coding by Blackbook), and pursuing outcome-oriented deals.

Recent highlights include an expanded partnership with VitalMD Group for their Scribble Suite and new revenue cycle management deals with StrideCare and a risk-bearing enablement company. IKS also earned the prestigious 2026 Best in KLAS Award for Virtual Scribing Services, reflecting strong customer experience.